Fertility and sterility · 2008
Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Al-Ozairi Ebaa, Quinton Richard, Advani Andrew
Аннотация
OBJECTIVE: To report a case where insulin sensitization restored menses in an underweight woman with polycystic ovarian syndrome (PCOS).
DESIGN: Case report.
SETTING: Tertiary care center.
PATIENT(S): A 19-year-old woman with a body mass index of 16.9 kg/m(2), severe hirsutism, and oligomenorrhea.
INTERVENTION(S): Insulin sensitization with metformin.
MAIN OUTCOME MEASURE(S): Impact of metformin therapy on menstrual cycle and serum T and fasting insulin levels.
RESULT(S): Metformin, without weight loss or increased physical activity, resulted in restoration of menstrual cycle, reduction in serum T, and improvement in insulin resistance (IR).
CONCLUSION(S): This case highlights the contribution of PCOS-related IR, distinct from visceral adiposity, and demonstrates the effectiveness of pharmacological insulin-sensitization independent of weight loss or lifestyle adjustments.
DESIGN: Case report.
SETTING: Tertiary care center.
PATIENT(S): A 19-year-old woman with a body mass index of 16.9 kg/m(2), severe hirsutism, and oligomenorrhea.
INTERVENTION(S): Insulin sensitization with metformin.
MAIN OUTCOME MEASURE(S): Impact of metformin therapy on menstrual cycle and serum T and fasting insulin levels.
RESULT(S): Metformin, without weight loss or increased physical activity, resulted in restoration of menstrual cycle, reduction in serum T, and improvement in insulin resistance (IR).
CONCLUSION(S): This case highlights the contribution of PCOS-related IR, distinct from visceral adiposity, and demonstrates the effectiveness of pharmacological insulin-sensitization independent of weight loss or lifestyle adjustments.